SGLT-2 Inhibitors, An Issue of Heart Failure Clinics

Description

In this issue, guest editors bring their considerable expertise to this important topic.

Table of Contents

• View Table of Contents

Author Information

Edited by Deepak L. Bhatt, MD, MPH, Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart and Vascular Center; Professor of Medicine, Harvard Medical School, Boston, Massachusetts, USA and Ragavendra R. Baliga, MD, MBA, Director, Section of Cardiovascular Medicine and Clinical Professor of Internal Medicine, Ohio State University, University Hospital East, Ohio, MI, USA